Demographics, clinical characteristics, treatment (tx) patterns and clinical outcomes for patients ( pts) with limited-stage SCLC (LS-SCLC)

被引：0
|
作者：
Chiang, A. C. [1 ]
Salomonsen, R. J-B. [2 ]
Wang, A. [2 ]
Holland, R. [3 ]
Cai, L. [2 ]
Xiao, Y. [2 ]
Sadow, S. [2 ]
Davey, K. [3 ]
Iyengar, P. [4 ]
机构：
[1] Yale Univ, Sch Med, Thorac Oncol, New Haven, CT USA
[2] AstraZeneca, Gaithersburg, MD USA
[3] AstraZeneca, Cambridge, England
[4] UT Southwestern Med Ctr Dallas, Dallas, TX USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
168P
引用
收藏
页码：S132 / S133
页数：2
相关论文
共 50 条
  • [21] Hypo- or Conventionally Fractionated Radiotherapy in Patients with Limited Stage Small Cell Lung Cancer (LS-SCLC): A Retrospective Analysis
    Zhang, Jing
    Fan, Min
    Liu, Di
    Shen, Yu Xin
    Zhao, Kuai Le
    Wu, Kai Liang
    Zhao, Wei Xin
    Li, Ling
    Fu, Xiao Long
    Zhu, Zheng Fei
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S500 - S500
  • [22] Treatment (tx) characteristics and clinical outcomes in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC) treated with carboplatin (carbo) or cisplatin (cis) in combination with etoposide (etop) in US clinical practice
    Sebastian, M.
    Barlesi, F.
    Califano, R.
    Mansfield, A. S.
    Blackhall, F. H.
    Flahavan, E. M.
    Davies, J.
    Arnold, P.
    Morris, S.
    Reck, M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [23] Validation of Immune-Scores for the Prediction of Survival in small cell Lung Cancer at localized limited Stage (LS-SCLC)
    Schnoeller, L.
    Kaesmann, L.
    Taugner, J.
    Eze, C.
    Roengvoraphoj, O.
    Belka, C.
    Manapov, F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S147 - S147
  • [24] PHASE II STUDY COMPARING ACCELERATED TWICE DAILY AND ONCE DAILY THORACIC RADIOTHERAPY IN PATIENTS WITH LIMITED-STAGE SMALL CELL LUNG CANCER (LS-SCLC) TREATED CONCURRENTLY WITH CHEMOTHERAPY
    Lee, C. E.
    Lorigan, P.
    Blackhall, F.
    Taylor, P.
    Ashcroft, L. F.
    Thatcher, N.
    Faivre-Finn, C.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S108 - S108
  • [25] Tracheoesophageal (TE) fistula development in a phase II trial of concurrent chemoradiation (CRT) and bevacizumab (B) in limited-stage small-cell lung cancer (LS-SCLC)
    Spigel, D. R.
    Hainsworth, J. D.
    Farley, C.
    Meng, C.
    Blake, D.
    Burris, H. A., III
    Raefsky, E.
    Patton, J.
    Hart, L. L.
    Greco, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [26] Thoracic Radiotherapy Within 6 Weeks with concurrent chemotherapy Improved Outcome of Patients with Limited Stage Small Cell Lung Cancer (LS-SCLC)
    Komaki, R. U.
    Allen, P.
    Wei, X.
    Gomez, D.
    Fossella, F.
    Heymach, J.
    Welsh, J.
    O'Reilly, M.
    Lin, S.
    Cox, J. D.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S217 - S217
  • [27] Effectiveness and Timing of Prophylactic Cranial Irradiation (PCI) in Limited Stage Small Cell Lung Carcinoma (LS-SCLC) Patients: A Single Institution Experience
    Turaka, A.
    Li, T.
    Naik, M. J.
    Unger, M.
    King, E.
    Shah, P. C.
    Scott, W. J.
    Borghaei, H.
    Buyyounouski, M. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S518 - S518
  • [28] Irinotecan (I), carboplatin (C), and radiotherapy (RT) followed by maintenance bevacizumab (B) in the treatment (tx) of limited-stage small cell lung cancer (LS-SCLC): Update of a phase II trial of the Minnie Pearl Cancer Research Network.
    Patton, J. F.
    Spigel, D. R.
    Greco, F. A.
    Liggett, W. H.
    Zubkus, J. D.
    Baskette, M.
    Schreeder, M.
    Woytowitz, D.
    Nelson, E.
    Hainsworth, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 385S - 385S
  • [29] Dose intensive chemotherapy for limited-stage (LS) small cell lung cancer (SCLC): A phase II study.
    Kubota, K
    Yoh, K
    Niho, S
    Goto, K
    Ohmatsu, H
    Tamura, T
    Ohe, Y
    Kunitoh, H
    Sekine, I
    Nishiwaki, Y
    Saijo, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 659S - 659S
  • [30] Phase II study of irinotecan (CPT-11) and cisplatin (CDDp) regimen (IP) with concurrent thoracic radiotherapy (TRT) in limited-stage small cell lung cancer (LS-SCLC)
    Castellano, Daniel
    Bartolome, A.
    Font, A.
    Coronado, Cinthya
    Diz, P.
    Lopez-Brea, M.
    Garrido, P.
    Lianes, P.
    Lopez, A.
    Paz-Ares, L.
    ANNALS OF ONCOLOGY, 2006, 17 : 229 - 230
12345